When cross validation of our fuzzy gene signatures was performed on public cohorts, equivocal profiles (all histologic grades included) represented a more or less significant part of tumors, ranging from 12 to 31.3% depending on the cohort.
← all excerpts
Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.
1
—
—